Key result
Valvular calcification linked to ~2.3-fold higher risk of persistent AF recurrence after ablation.
Why the study?
Valvular calcification is an independent risk factor for cardiovascular diseases, but its relationship with atrial fibrillation is not clear.
Does valvular calcification predict the recurrence of atrial fibrillation in patients with persistent atrial fibrillation after radiofrequency catheter ablation?
Cohort (n=2,687)
No
Does valvular calcification predict the recurrence of atrial fibrillation in patients with persistent atrial fibrillation after radiofrequency catheter ablation?
Valvular calcification can serve as an accessible echocardiographic marker to predict the risk of AF recurrence after ablation in patients with persistent atrial fibrillation.
Answers are grounded in this paper and cite their sources.
May inform recurrence risk stratification after ablation in persistent AF; hypothesis-generating and requires prospective validation.
BACKGROUND: Valvular calcification (VC) is an independent risk factor for cardiovascular diseases. The relationship between VC and atrial fibrillation is not clear. HYPOTHESIS: We treated the aortic valve, mitral valve, and tricuspid valve as a whole and considered the possible association between VC and recurrence of persistent atrial fibrillation (PsAF) after radiofrequency catheter ablation (RFCA). METHODS: This study involved 2687 PsAF patients who underwent RFCA. Data were collected to explore the relationship between VC and outcome. VC was defined by echocardiography in aortic valve, mitral valve, or tricuspid valve. After 1 year follow-up, subgroup analysis, mixed model regression analysis, and score system analysis were performed. The external validation of 133 patients demonstrated the accuracy of this clinical prediction model. RESULTS: Overall, 2687 inpatients were assigned to the recurrence group (n = 682) or the no recurrence group (n = 2005) with or without VC. Compared to patients with no recurrence, the incidence of VC was higher in recurrence patients. Recurrence was present in 18.5%, 34.9%, 39.3%, and 52.0% of the four groups, which met VC numbers of 0, 1, 2, and 3, respectively. After adjustment for potential confounding factors, VC was an independent risk factor for AF recurrence in several models. For multivariable logistic regression, a scoring system was established based on the regression coefficient. The receiver operating characteristic area of the scoring system was 0.787 in the external validation cohort. CONCLUSIONS: VC was an independent risk factor for AF recurrence in PsAF after RFCA. The scoring system may be a useful clinical tool to assess AF recurrence.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2023) conducted a cohort in Persistent atrial fibrillation (n=2,687). Valvular calcification vs. No valvular calcification was evaluated on Atrial fibrillation recurrence at 1 year (OR 2.291, 95% CI 1.843-2.703, p=<0.001). Valvular calcification was independently associated with an increased risk of persistent atrial fibrillation recurrence after radiofrequency catheter ablation (OR 2.291).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: